112 related articles for article (PubMed ID: 37664931)
21. TGF-β-activated SMAD3/4 complex transcriptionally upregulates N-cadherin expression in non-small cell lung cancer.
Yang H; Wang L; Zhao J; Chen Y; Lei Z; Liu X; Xia W; Guo L; Zhang HT
Lung Cancer; 2015 Mar; 87(3):249-57. PubMed ID: 25595426
[TBL] [Abstract][Full Text] [Related]
22. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
23. Ligand independent aryl hydrocarbon receptor inhibits lung cancer cell invasion by degradation of Smad4.
Lee CC; Yang WH; Li CH; Cheng YW; Tsai CH; Kang JJ
Cancer Lett; 2016 Jul; 376(2):211-7. PubMed ID: 27060206
[TBL] [Abstract][Full Text] [Related]
24. Akt SUMOylation regulates cell proliferation and tumorigenesis.
Li R; Wei J; Jiang C; Liu D; Deng L; Zhang K; Wang P
Cancer Res; 2013 Sep; 73(18):5742-53. PubMed ID: 23884910
[TBL] [Abstract][Full Text] [Related]
25. RGS6 suppresses TGF-β-induced epithelial-mesenchymal transition in non-small cell lung cancers via a novel mechanism dependent on its interaction with SMAD4.
Wang Z; Chen J; Wang S; Sun Z; Lei Z; Zhang HT; Huang J
Cell Death Dis; 2022 Jul; 13(7):656. PubMed ID: 35902557
[TBL] [Abstract][Full Text] [Related]
26. SUMOylation of vascular endothelial growth factor receptor 2 inhibits the proliferation, migration, and angiogenesis signaling pathway in non-small cell lung cancer.
Wang M; Jiang X
Anticancer Drugs; 2020 Jun; 31(5):492-499. PubMed ID: 31922962
[TBL] [Abstract][Full Text] [Related]
27. CREB SUMOylation by the E3 ligase PIAS1 enhances spatial memory.
Chen YC; Hsu WL; Ma YL; Tai DJ; Lee EH
J Neurosci; 2014 Jul; 34(29):9574-89. PubMed ID: 25031400
[TBL] [Abstract][Full Text] [Related]
28. Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.
Chanda A; Chan A; Deng L; Kornaga EN; Enwere EK; Morris DG; Bonni S
PLoS One; 2017; 12(5):e0177639. PubMed ID: 28493978
[TBL] [Abstract][Full Text] [Related]
29. Protein inhibitor of activated STAT1 Ser
Liu SY; Ma YL; Hsu WL; Chiou HY; Lee EHY
Br J Pharmacol; 2019 Jun; 176(11):1793-1810. PubMed ID: 30849179
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-205 targets SMAD4 in non-small cell lung cancer and promotes lung cancer cell growth in vitro and in vivo.
Zeng Y; Zhu J; Shen D; Qin H; Lei Z; Li W; Liu Z; Huang JA
Oncotarget; 2017 May; 8(19):30817-30829. PubMed ID: 28199217
[TBL] [Abstract][Full Text] [Related]
31. Ginkgolic acid improves bleomycin-induced pulmonary fibrosis by inhibiting SMAD4 SUMOylation.
Yu L; Bian X; Zhang C; Wu Z; Huang N; Yang J; Jin W; Feng Z; Li D; Huo X; Wu T; Jiang Z; Liu X; Sun D
Oxid Med Cell Longev; 2022; 2022():8002566. PubMed ID: 35707278
[TBL] [Abstract][Full Text] [Related]
32. CDCA7 promotes TGF-β-induced epithelial-mesenchymal transition via transcriptionally regulating Smad4/Smad7 in ESCC.
Li H; Wang S; Li X; Weng Y; Guo D; Kong P; Cheng C; Wang Y; Zhang L; Cheng X; Cui Y
Cancer Sci; 2023 Jan; 114(1):91-104. PubMed ID: 36056599
[TBL] [Abstract][Full Text] [Related]
33. PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation.
Xie B; Liu X; Yang J; Cheng J; Gu J; Xue S
BMC Cell Biol; 2018 Nov; 19(1):24. PubMed ID: 30419807
[TBL] [Abstract][Full Text] [Related]
34. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
35. Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.
Chen Z; Zhang Y; Guan Q; Zhang H; Luo J; Li J; Wei W; Xu X; Liao L; Wong J; Li J
J Biol Chem; 2021 Oct; 297(4):101200. PubMed ID: 34537242
[TBL] [Abstract][Full Text] [Related]
36. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
37. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
[TBL] [Abstract][Full Text] [Related]
38. Sirtuin 7 promotes non‑small cell lung cancer progression by facilitating G1/S phase and epithelial‑mesenchymal transition and activating AKT and ERK1/2 signaling.
Zhao Y; Ye X; Chen R; Gao Q; Zhao D; Ling C; Qian Y; Xu C; Tao M; Xie Y
Oncol Rep; 2020 Sep; 44(3):959-972. PubMed ID: 32705247
[TBL] [Abstract][Full Text] [Related]
39. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death.
Leitao BB; Jones MC; Brosens JJ
FASEB J; 2011 Oct; 25(10):3416-25. PubMed ID: 21676946
[TBL] [Abstract][Full Text] [Related]
40. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
